| Energy achievement rate |  | ||
---|---|---|---|---|
 | Low (n = 31) | Middle (n = 31) | High (n = 31) | P value |
Characteristic | Â | Â | Â | Â |
 7-day energy achievement ratea | 16.8 (7.8–22.7) | 38.8 (35.3–44.0) | 73.4 (63.5–87.6) | < 0.0001 |
 7-day energy supply (kcal) | 1500 (810–2025) | 3156 (2895–3873) | 5500 (4334–7277) | < 0.0001 |
 7-day protein supply (g) | 67.5 (48–122) | 130 (100–158) | 209 (150–279) | < 0.0001 |
Percentage of macronutrients (%) | Â | Â | Â | Â |
 Carbohydrates | 56 (33–64) | 63 (56–63) | 63 (34–65) | 0.43 |
 Protein | 20 (15–34) | 19 (15–20) | 20 (17–20) | 0.069 |
 Fat | 24 (15–33) | 18 (15–25) | 17 (15–25) | 0.97 |
Age, years | 77 (71–82) | 74 (66–80) | 76 (69–83) | 0.42 |
Male sex, n (%) | 22 (70.9) | 18 (58.1) | 15 (48.4) | 0.22 |
BMI on ICU admission (kg/m²) | 21.4 (18.4–23.4) | 20.5 (19.5–23.7) | 20.4 (18.4–21.7) | 0.58 |
SMA on ICU admission (cm²) | 107.5 (87.8-123.8) | 94.7 (81.2-132.4) | 84.9 (68.7–98.3) | 0.015 |
Comorbidity, n (%) | Â | Â | Â | Â |
 Malignancy | 7 (22.6) | 8 (25.8) | 3 (9.7) | 0.25 |
 Hypertension | 11 (35.5) | 9 (29.0) | 5 (16.1) | 0.27 |
 Diabetes mellitus | 8 (25.8) | 12 (38.7) | 10 (32.3) | 0.59 |
 Heart failure | 4 (12.9) | 6 (19.4) | 7 (22.6) | 0.71 |
 Chronic kidney disease | 6 (19.4) | 3 (9.7) | 2 (6.5) | 0.37 |
 Chronic liver disease | 1 (3.2) | 2 (6.5) | 3 (9.7) | 0.87 |
 Chronic lung disease | 1 (3.2) | 3 (9.7) | 2 (6.5) | 0.87 |
Charlson comorbidity index | 7 (5–7) | 6 (4–8) | 6 (5–7) | 0.57 |
SOFA score on admission | 9 (5–12) | 10 (9–13) | 9 (6–13) | 0.18 |
APACHE II score | 25 (18–28) | 26 (22–30) | 23 (20–28) | 0.85 |
mNUTRIC score | 6 (4–7) | 6 (5–7) | 5 (5–7) | 0.36 |
Septic shock, n (%) | 18 (58.1) | 10 (32.3) | 13 (41.9) | 0.34 |
Steroid use before admission, n (%) | 6 (19.4) | 3 (9.7) | 4 (12.9) | 0.66 |
Etiology of sepsis, n (%) | Â | Â | Â | Â |
 Pneumonia | 3 (9.7) | 10 (32.3) | 6 (19.4) | 0.10 |
 Urinary tract infection | 17 (54.8) | 10 (32.3) | 12 (38.7) | 0.22 |
 Intra-abdominal infection | 5 (16.1) | 3 (9.7) | 5 (16.1) | 0.81 |
 Other | 6 (19.4) | 8 (25.8) | 8 (25.8) | 0.87 |
CT interval (days) | 8 (7–10) | 8 (7–10) | 8 (7–9) | 0.75 |
Nutritional intervention, n (%) | Â | Â | Â | Â |
 Parenteral nutrition |  |  |  |  |
  Total parenteral nutrition | 9 (29.0) | 12 (38.7) | 14 (45.2) | 0.63 |
  Peripheral parenteral nutrition | 4 (12.9) | 1 (3.2) | 0 (0.0) | 0.12 |
 Enteral nutrition |  |  |  |  |
  Gastric tube feeding | 14 (45.2) | 17 (54.8) | 17 (54.8) | 0.78 |
  Jejunal tube feeding | 4 (12.9) | 1 (3.2) | 0 (0.0) | 0.12 |
 Enteral and parenteral nutrition | 11 (35.5) | 11 (35.5) | 8 (25.8) | 0.64 |
Outcome | Â | Â | Â | Â |
 Percent changes in SMA (%) | -8.5 (-15.5 to -1.7) | -11.7 (-18.0 to -1.9) | 2.8 (-7.1 to 10.1) | 0.0046 |
 In-hospital 28-day mortality, n (%) | 7 (22.6) | 9 (29.0) | 6 (19.4) | 0.75 |